BioSource International Posts Sales of $5.18 Million
- Share via
Third-quarter results for BioSource International in Camarillo were the second best in the company’s history, with revenues of $5.18 million and net income of $855,401--or 10 cents per share--for the three months ending Sept. 30.
The figures were comparable to the three months that ended Sept. 30, 1996, when BioSource reported revenues of $5.04 million and net income of $806,380, or 10 cents per share.
“We are pleased to report continued solid revenue and earnings even during the typically slow summer quarter, when business activity is reduced in both our domestic and European operations,” said James H. Chamberlain, BioSource chairman, president and chief executive officer. “This consistent performance is steadily building total stockholders’ equity, while supporting continued investment in product development and expanded market education programs for new products.”
BioSource supplies immunological reagents and test kits used in biomedical research. The company has more than 1,300 products.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.